Do you want to read an article? Please log in or register.
Precision surgery for colorectal liver metastases: Opportunities and challenges of omics-based decision making
Gastrointestinal Cancer
Related content
Gastrointestinal Cancer
Population-based SEER analysis of survival in colorectal cancer patients with or without resection of lung and liver metastases
BMC Cancer.
Siebenhüner AR, Güller U, Warschkow R
doi: 10.1186/s12885-020-6710-1.
Gastrointestinal Cancer
Treatment strategies and outcome of surgery for synchronous colorectal liver metastases
Swiss Med Wkly.
Reding D, Pestalozzi BC, Breitenstein S, Stupp R, Clavien PA, Slankamenac K, Samaras P
doi: 10.4414/smw.2017.14486.
Gastrointestinal Cancer
Hepatotoxicity following systemic therapy for colorectal liver metastases and the impact of chemotherapy-associated liver injury on outcomes after curative liver resection
Eur J Surg Oncol.
Duwe G, Knitter S, Pesthy S, Beierle AS, Bahra M, Schmelzle M, Schmuck RB, Lohneis P, Raschzok N, Öllinger R, Sinn M, Struecker B, Sauer IM, Pratschke J, Andreou A
doi: 10.1016/j.ejso.2017.05.008.
Gastrointestinal CancerFurther Publications
Targeting the Tumor in Colorectal Cancer – Where do we Stand with Precision Medicine in 2020
★ 3
Recommended and commented by
Alexander Meisel, Faculty Member
healthbook TIMES Oncology Hematology
Corresponding author:
Dr Alexander Siebenhüner
Senior Consultant in Medical Oncology
Cantonal Hospital Schaffhausen
Schaffhausen, Switzerland
Gastrointestinal Cancer
Multimodal treatment strategies for colorectal liver metastases
Swiss Med Wkly
Birrer DL, Tschuor C, Reiner C, Fritsch R, Pfammatter T, Garcia Schüler H, Pavic M, De Oliveira M, Petrowsky H, Dutkowski P, Oberkofler C, Clavien PA
doi: 10.4414/smw.2021.20390
RECOMMENDED
Gastrointestinal CancerRadio-Oncology
The impact of local control on overall survival after stereotactic body radiotherapy for liver and lung metastases from colorectal cancer: a combined analysis of 388 patients with 500 metastases
BMC Cancer.
Klement RJ, Abbasi-Senger N, Adebahr S, Alheid H, Allgaeuer M, Becker G, Blanck O, Boda-Heggemann J, Brunner T, Duma M, Eble MJ, Ernst I, Gerum S, Habermehl D, Hass P, Henkenberens C, Hildebrandt G, Imhoff D, Kahl H, Klass ND, Krempien R, Lewitzki V, Lohaus F, Ostheimer C, Papachristofilou A, Petersen C, Rieber J, Schneider T, Schrade E, Semrau R, Wachter S, Wittig A, Guckenberger M, Andratschke N
doi: 10.1186/s12885-019-5362-5.
Gastrointestinal CancerRadio-Oncology
First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials
Lancet Oncol.
Wasan HS, Gibbs P, Sharma NK, Taieb J, Heinemann V, Ricke J, Peeters M, Findlay M, Weaver A, Mills J, Wilson C, Adams R, Francis A, Moschandreas J, Virdee PS, Dutton P, Love S, Gebski V, Gray A; FOXFIRE trial investigators; SIRFLOX trial investigators; FOXFIRE-Global trial investigators, van Hazel G, Sharma RA
doi: 10.1016/
Gastrointestinal Cancer
Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial
Lancet Oncol
Quénet F, Elias D, Roca L, Goéré D, Ghouti L, Pocard M, Facy O, Arvieux C, Lorimier G, Pezet D, Marchal F, Loi V, Meeus P, Juzyna B, de Forges H, Paineau J, Glehen O, UNICANCER-GI Group and BIG Renape Group.
doi: 10.1016/S1470-2045(20)30599-4
COMMENTED
Gastrointestinal Cancer
Second-look surgery plus hyperthermic intraperitoneal chemotherapy versus surveillance in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP-PRODIGE 15): a randomised, phase 3 study
★ 3
Recommended and commented by
PD Dr Sara De Dosso, Faculty Member
Lancet Oncol.
Goéré D, Glehen O, Quenet F, Guilloit JM, Bereder JM, Lorimier G, Thibaudeau E, Ghouti L, Pinto A, Tuech JJ, Kianmanesh R, Carretier M, Marchal F, Arvieux C, Brigand C, Meeus P, Rat P, Durand-Fontanier S, Mariani P, Lakkis Z, Loi V, Pirro N, Sabbagh C, Texier M, Elias D, BIG-RENAPE group
doi: 10.1016/S1470-2045(20)30322-3.